74 related articles for article (PubMed ID: 12185592)
1. Dominant negative MEKK1 inhibits survival of pancreatic cancer cells.
Hirano T; Shino Y; Saito T; Komoda F; Okutomi Y; Takeda A; Ishihara T; Yamaguchi T; Saisho H; Shirasawa H
Oncogene; 2002 Aug; 21(38):5923-8. PubMed ID: 12185592
[TBL] [Abstract][Full Text] [Related]
2. Survival regulation in pancreatic cancer cells by c-Jun.
Okutomi Y; Shino Y; Komoda F; Hirano T; Ishihara T; Yamaguchi T; Saisho H; Shirasawa H
Int J Oncol; 2003 Oct; 23(4):1127-34. PubMed ID: 12963995
[TBL] [Abstract][Full Text] [Related]
3. MEKK1 induces c-Jun complexes that act as negative regulators for cell survival and proliferation of HCC cells.
Komoda F; Shino Y; Hirano T; Okutomi Y; Okamoto H; Hayashi Y; Suyama T; Ebara M; Saisho H; Shirasawa H
Int J Oncol; 2002 Sep; 21(3):553-9. PubMed ID: 12168099
[TBL] [Abstract][Full Text] [Related]
4. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
Jin K; Park S; Ewton DZ; Friedman E
Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
[TBL] [Abstract][Full Text] [Related]
5. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
Xiao L; Lang W
Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
[TBL] [Abstract][Full Text] [Related]
6. Activation of Raf-1 in human pancreatic adenocarcinoma.
Berger DH; Jardines LA; Chang H; Ruggeri B
J Surg Res; 1997 Apr; 69(1):199-204. PubMed ID: 9202670
[TBL] [Abstract][Full Text] [Related]
7. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
9. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1.
Widmann C; Johnson NL; Gardner AM; Smith RJ; Johnson GL
Oncogene; 1997 Nov; 15(20):2439-47. PubMed ID: 9395240
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
12. The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways.
Boldt S; Weidle UH; Kolch W
Exp Cell Res; 2003 Feb; 283(1):80-90. PubMed ID: 12565821
[TBL] [Abstract][Full Text] [Related]
13. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
14. [Heat shock activated Rac-MEKK-JNK pathway and hsp90 beta gene expression].
Li XY; Lu C; Wu NH; Shen YF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):264-8. PubMed ID: 12905631
[TBL] [Abstract][Full Text] [Related]
15. Axin utilizes distinct regions for competitive MEKK1 and MEKK4 binding and JNK activation.
Luo W; Ng WW; Jin LH; Ye Z; Han J; Lin SC
J Biol Chem; 2003 Sep; 278(39):37451-8. PubMed ID: 12878610
[TBL] [Abstract][Full Text] [Related]
16. The TAO of MEKK.
Schlesinger TK; Fanger GR; Yujiri T; Johnson GL
Front Biosci; 1998 Nov; 3():D1181-6. PubMed ID: 9820741
[TBL] [Abstract][Full Text] [Related]
17. An analog of withaferin A activates the MAPK and glutathione "stress" pathways and inhibits pancreatic cancer cell proliferation.
Liu X; Qi W; Cooke LS; Kithsiri Wijeratne EM; Xu YM; Marron MT; Leslie Gunatilaka AA; Mahadevan D
Cancer Invest; 2011 Dec; 29(10):668-75. PubMed ID: 22085270
[TBL] [Abstract][Full Text] [Related]
18. [Down-regulated expression of PP2A catalytic subunit in pancreatic cancer cells promotes cell growth].
Li W; Gong F; Chen Z; Zong Y; Chen K; Li D; Tao M; Xu Z
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):86-9. PubMed ID: 24721345
[TBL] [Abstract][Full Text] [Related]
19. Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells.
Su F; Li H; Yan C; Jia B; Zhang Y; Chen X
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1655-63. PubMed ID: 19513748
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor alpha activates Ha-Ras in human pancreatic cancer cells with Ki-ras mutations.
Seufferlein T; Van Lint J; Liptay S; Adler G; Schmid RM
Gastroenterology; 1999 Jun; 116(6):1441-52. PubMed ID: 10348828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]